The aim of Translational biomedicine is to promote basic scientific research for the well-being of humankind. The scientific discipline of Translational medicine encourages the research towards therapeutic interventions which not only brings forward the possible therapeutics but also highlights the research gaps in research specific area. The Issue 3 Volume 11 of Translational Biomedicine showcases a wide range of studies such as the usage of plant phytoderivatives as fusion inhibitors targeting the spike proteins in order to inhibit the entry of COVID-19, role of stem cells in Chronic myeloid leukaemia, the effect of Avastin for the treatment of Neovascular Age related Macular Degeneration.
